Industry Analysis & Industry Trends
The use of medication for the treatment of attention deficit disorders, such as ADHD, is growing. The recent recognition of ADHD as a condition that can also afflict adults has provided a boon to the industry, and healthcare reform has enabled more children to access behavioral health services, resulting in more patients being able to have their ADHD identified and treated. In the five years to 2021, industry revenue will continue to grow as the trends from the previous five years bolster utilization rates. However, many brand-name drugs are set to lose their patent exclusivity, which will incite more generic drug manufacturers to inundate the market with low-cost drugs, intensifying price-based competition... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The ADHD Medication Manufacturing industry is currently in the growth life cycle stage. During the 10 years to 2021, industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to grow at an annualized rate of 6.2%. Comparatively, US GDP is anticipated to grow at an annualized 2.1% over the same period. According to data from Healthline, the number of individuals treated for ADHD in the United States has skyrocketed 42.0% over the eight years to 2014 (latest data available), which has provided a boon to the industry. Further benefiting the industry, in 2013, the American Psychiatric Association established guidelines for healthcare providers to diagnose adults with ADHD.
.. purchase to read more